Cortistatin-14 vs PACAP — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Cortistatin-14 (CST-14) is a cyclic neuropeptide with strong structural homology to somatostatin-14, sharing 11 of 14 residues. It activates all five somatostatin receptors (SSTR1-5) with similar affinity to somatostatin, but also binds additional receptors including the ghrelin ...
Calculate Cortistatin-14 dose →Pituitary adenylate cyclase-activating polypeptide (PACAP) is a pleiotropic neuropeptide belonging to the secretin/glucagon/VIP superfamily. It was originally isolated from ovine hypothalamus for its ability to stimulate adenylate cyclase in pituitary cells....
Calculate PACAP dose →| Parameter | Cortistatin-14 | PACAP |
|---|---|---|
| Category | Neuropeptide / Neuromodulator | Neuropeptide / Neuromodulator |
| Research | Preclinical | Preclinical / Phase 2 |
| Half-Life | Short (minutes) | 3-10 minutes (IV) |
| Typical Dose | N/A (preclinical) | 1-10 pmol/kg/min (IV research) |
| Frequency | N/A | Variable |
| Route | ICV / IV (research) | IV / SC / Intranasal (research) |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.